EPE Special Opportunities
Limited
("ESO" or the
"Company")
Trading
Statement
The Board of EPE Special
Opportunities is pleased to provide an update on the Company's
performance for the year ended 31 January 2025.
· The Company and its portfolio have faced a challenging
environment during the year ended 31 January 2025 against the
backdrop of an uncertain and complex economic landscape. The Board
and Investment Advisor continue to manage the Company prudently,
prioritising liquidity and securing the financial position of the
portfolio. Given the economic context, overall M&A activity has
remained subdued and market valuations have been depressed,
limiting the opportunities for new acquisitions and disposals in
the period. The operational improvements and progress made against
long term value creation plans within the portfolio, position our
businesses for sustained growth as macro economic conditions
stabilise.
·
The unaudited estimate of the Net Asset Value
("NAV") per share of the Company as at 31 January 2025 was 328
pence, representing an increase of 1 per cent. on the NAV per share
of 324 pence as at 31 January 2024. The unaudited estimate has been
prepared using the Company's historic valuation methodology and
accounting principles.
·
The share price of the Company as at 31 January
2025 was 149 pence, representing a decrease of 10 per cent. on the
share price of 165 pence as at 31 January 2024.
·
In January 2025, Luceco released a
trading update for the year ended 31 December 2024, announcing
results ahead of market expectations. The group announced sales in
the region of £240 million, achieving organic growth of 5 per cent.
on the prior year on a constant currency basis. The business
delivered strong Q4 trading, with impressive sales growth in the
Residential RMI division as well as the Residential EV Charger
division, which delivered quarterly year-on-year growth of circa
50%. The business expects to generate operating profit in the
region of £28.5 - 29.0 million for the year. Luceco completed two
acquisitions in the period, acquiring D-Line, a supplier of cable
management solutions, for £8.6 million initial consideration and up
to £3.8m million contingent consideration in March 2024, and CMD, a
wiring accessories manufacturer for commercial premises, for £30.0
million consideration in October 2024. The business' balance sheet
remains robust with net debt of 1.7x LTM EBITDA as at 31 December
2024, within the the target range of 1.0-2.0x.
·
Whittard of Chelsea ("Whittard") delivered
pleasing growth across its sales channels. The UK retail store
estate performed strongly, achieving 6% like for like sales growth
and opening new stores in Oxford Circus, Gatwick Airport and
Victoria Station. Whittard has continued to develop its
international channels, with expansion in the US market underpinned
by new customers wins with key retailer accounts, including Sam's
Club. The business has also continued to improve its customer
proposition, with a new customer loyalty programme launched in the
period.
· The Rayware Group
("Rayware") continued to face headwinds to trading performance, but
has made progress on the development of its overall channel
strategy in the period. In August 2024 Rayware launched a new
retail channel, with its first store opened in Swindon. Rayware's
US channel achieved pleasing growth, securing new customer wins.
Rayware appointed a CEO in May-24, Jamie O'Brien, who brings to the
business over 20 years' leadership experience in the branded
consumer sector. During the period, the Company, through its
subsidiary ESO Investments 1 Limited, invested £3.5 million to
reduce Rayware's senior debt and has a £1.0 million contingent
guarantee outstanding to third-party lenders as at 31 January
2025.
·
Pharmacy2U ("P2U") maintained strong organic
growth during the period and accelerated its underlying growth
trajectory via acquisition. The integration of LloydsDirect was
approved by the CMA in March 2024, delivering material additional
scale to the platform and synergy opportunities. In April 2024, P2U
expanded its offering to include pet care, via the acquisition of
The PharmaPet Co.
·
David Phillips ("DP") continues to experience
profitability headwinds but enters the year with an encouraging
pipeline. In July 2024, Ben Munn joined the business as CEO, with
over 25 years of experience in the real estate sector. In January
2025, the Company, through its subsidiary ESO Investments 1
Limited, invested £0.7 million to support the business.
·
Denzel's achieved top line growth, expanding their
offering within key retailers and securing new accounts. The
business' marketing activity has been supported by new partnerships
such as the collaboration with Battersea Dogs & Cats Home,
launched in June 2024.
·
The Company had cash balances of £11 million1 as at 31
January 2025. In July 2024, the Company
agreed the extension of the maturity of £4.0 million of unsecured
loan notes to July 2025. In the period, the Company repurchased 3.0
million zero dividend preference ("ZDP") shares. Following this
buyback, the Company has 9.5 million ZDP shares remaining in issue,
maturing in December 2026. The Company has no other
third-party debt outstanding. In the period, the Company completed
ordinary share buybacks in the market totalling 0.6 million
ordinary shares at a weighted average share price of 152
pence.
·
As at 31 January 2025, the Company's unquoted
portfolio was valued at a weighted average EBITDA to enterprise
value multiple of 7.8x and the portfolio has a low level of
third-party leverage with net debt at 1.2x EBITDA in
aggregate.
Mr Clive Spears, Chairman,
commented: "Due to the complex business conditions faced in the
period, the priority of the Board, Investment Advisor and portfolio
management teams has been to ensure the resilience of the Company
and its portfolio against these headwinds. Value creation plans are
in place within the portfolio to generate future growth, with close
monitoring of progress maintained. Prudent action has been taken to
preserve liquidity and to manage the capital structure of the
Company. The Board would like to extend their thanks to the
Investment Advisor and portfolio management teams for their efforts
through a demanding period and look forward to updating
shareholders on further progress at the half year."
The person responsible for releasing
this information on behalf of the Company is Amanda Robinson of
Langham Hall Fund Management (Jersey) Limited.
Note 1: Company liquidity is stated inclusive of cash held by
subsidiaries in which the Company is the sole
investor.
Enquiries:
EPIC Investment Partners LLP
|
+44 (0) 207 269 8865
Rupert Palmer
|
Langham Hall Fund Management (Jersey)
Limited
|
+44 (0) 15 3488 5200
Amanda Robinson
|
Cardew Group Limited
|
+44 (0) 207 930 0777
Richard Spiegelberg
|
Deutsche Numis
|
+44 (0) 207 260 1000
|
Nominated Advisor:
|
Stuart Skinner
|
Corporate Broker:
|
Charles Farquhar
|